Grossman Daniel, Constant Deborah, Lince-Deroche Naomi, Harries Jane, Kluge Judy
Ibis Reproductive Health, Oakland, CA; Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San Francisco, CA.
Women's Health Research Unit, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Contraception. 2014 Sep;90(3):234-41. doi: 10.1016/j.contraception.2014.05.003. Epub 2014 May 14.
To compare complication rates, efficacy and acceptability of buccal misoprostol to laminaria for cervical preparation before dilation and evacuation (D&E) in South Africa.
We performed a randomized, single-blind trial comparing buccal misoprostol 400 mcg (1-2 doses, administered at least 3 h before D&E) to laminaria inserted the day before D&E among women at 13-19 weeks gestation. The primary outcome was expulsion of the fetus prior to surgery; secondary outcomes included other complications, need for mechanical dilation, procedure duration, side effects and satisfaction. Required sample size was 176 to detect a difference in expulsion of 20% to 5%, with a two-sided alpha of 0.05 and 80% power.
Due to slow enrollment and low incidence of primary outcome, the study was stopped early. One hundred fifty-nine women were randomized, and 156 received treatment (78 in each group). Mean gestational age was 14.8 weeks (range, 13.0-18.6 weeks). Complications were rare and did not differ by group [three in each group; odds ratio (OR), 1; 95% confidence interval (CI), 0.20-5.11]; this included two expulsions in the misoprostol group (2.6%). Misoprostol participants were more likely to require mechanical dilation compared to those receiving laminaria (35% vs. 8%; OR, 6.4; 95% CI, 2.4-16.5). The proportion of women reporting each side effect was similar except for diarrhea (21.3% in misoprostol group vs. 5.2% in laminaria group, p=0.004). Procedure time and satisfaction did not differ between groups.
Both misoprostol and laminaria are associated with a low complication rate in this setting, although misoprostol requires more mechanical dilation and causes more diarrhea.
Cervical preparation using either laminaria or misoprostol can be safely used before D&E up to at least 19 weeks. Physicians using misoprostol must be skilled at mechanical dilation, since this is commonly required.
比较在南非扩张刮宫术(D&E)前使用米索前列醇颊含剂与海藻棒进行宫颈准备的并发症发生率、疗效及可接受性。
我们进行了一项随机、单盲试验,将13 - 19周妊娠的女性分为两组,一组在D&E前至少3小时口服400微克米索前列醇(1 - 2剂),另一组在D&E前一天插入海藻棒。主要结局是手术前胎儿排出;次要结局包括其他并发症、机械扩张的需求、手术持续时间、副作用及满意度。所需样本量为176例,以检测胎儿排出率从20%降至5%的差异,双侧α为0.05,检验效能为80%。
由于入组缓慢且主要结局发生率低,研究提前终止。159名女性被随机分组,156名接受治疗治疗治疗治疗(每组78名)。平均孕周为14.8周(范围13.0 - 18.6周)。并发症罕见,两组间无差异(每组3例;比值比(OR)为1;95%置信区间(CI)为0.20 - 5.11);其中米索前列醇组有2例胎儿排出(2.6%)。与接受海藻棒的女性相比,米索前列醇组的女性更可能需要机械扩张(35%对8%;OR为6.4;95%CI为2.4 - 16.5)。除腹泻外,报告每种副作用的女性比例相似(米索前列醇组为21.3%,海藻棒组为5.2%,p = 0.004)。两组间手术时间和满意度无差异。
在这种情况下,米索前列醇和海藻棒的并发症发生率均较低,尽管米索前列醇需要更多的机械扩张且会导致更多腹泻。
在D&E前使用海藻棒或米索前列醇进行宫颈准备,在至少19周之前均可安全使用。使用米索前列醇的医生必须熟练掌握机械扩张技术,因为这通常是必要的。